Hans-Peter Albert Ostler

Hans-Peter Albert Ostler currently works at Alligator Bioscience AB, as Chairman, Ectin Research AB, as Chairman from 2022, Improve Tec Hönö AB, as Chairman, Vakona AB, as Chairman, Larkberget AB, as Chairman from 2026, Ancoria Insurance Ltd., as Director, Entreprenörskapital i Sverige AB, as Director, Oblique Therapeutics AB, as Director, O Mgmt AB, as Deputy Director, Inorbit Therapeutics AB, as Director, RGNT Electric AB, as Director, SP HMSO Göteborg AB, as Director, Lennart ekerholms stiftelse, as Director, Hoodin AB, as Director from 2021, Opsy Holding AB, as Director from 2024, ENCare AB, as Director, and Söderberg & Partners Holding AB, as Wealth Manager.
Mr. Ostler also formerly worked at TikoMed AB, as Chief Executive Officer, Promore Pharma AB, as Independent Director, and IRLAB Therapeutics AB, as Independent Director from 2016 to 2017.
Mr. Ostler received his undergraduate degree and graduate degree from Handelshögskolan i Göteborg.